Equillium, Inc. Files 8-K on Financials

Ticker: EQ · Form: 8-K · Filed: Mar 25, 2024 · CIK: 1746466

Equillium, INC. 8-K Filing Summary
FieldDetail
CompanyEquillium, INC. (EQ)
Form Type8-K
Filed DateMar 25, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, disclosure

Related Tickers: EQIL

TL;DR

Equillium filed an 8-K on March 25, 2024, updating on financial condition and results.

AI Summary

On March 25, 2024, Equillium, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.

Why It Matters

This filing provides an update on Equillium's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — The filing is a standard disclosure of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Equillium, Inc.?

The primary purpose of this 8-K filing is to report on Equillium, Inc.'s results of operations and financial condition, as well as to provide financial statements and exhibits.

On what date was this 8-K report filed?

This 8-K report was filed on March 25, 2024.

In which state is Equillium, Inc. incorporated?

Equillium, Inc. is incorporated in Delaware.

What is the principal executive office address for Equillium, Inc.?

The principal executive office address for Equillium, Inc. is 2223 Avenida de la Playa, Suite 105, La Jolla, California 92037.

What is the SEC file number for Equillium, Inc.?

The SEC file number for Equillium, Inc. is 001-38692.

Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-03-25 16:05:36

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated March 25, 2024. 104 Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Equillium, Inc. Dated: March 25, 2024 By: /s/ Jason A. Keyes Jason A. Keyes Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing